University of Texas MD Anderson Cancer Center Researchers Report Recent Findings in Thymic Cancer (S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or ...)

Press/Media

PeriodDec 2 2024

Media coverage

1

Media coverage

  • TitleUniversity of Texas MD Anderson Cancer Center Researchers Report Recent Findings in Thymic Cancer (S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or ...)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date12/2/24
    PersonsMartin Edelman